Accumulating evidence suggests that DUSP9 is downregulated and acts as a tumor suppressor in many kinds of cancers, such as gastric cancer, hepatocellular carcinomas, renal cancer, squamous cell carcinoma (SCC), etc. (9–12). Here, DUSP9 is linked to neoplasm.